Brier M E, Mayer P R, Brier R A, Visscher D, Luft F C, Aronoff G R
Antimicrob Agents Chemother. 1985 May;27(5):812-6. doi: 10.1128/AAC.27.5.812.
Gentamicin, tobramycin, and netilmicin were given to rats in daily doses of either 5 or 20 mg/kg for 30 days to determine the renal accumulation kinetics of the compounds and to correlate steady-state renal parenchymal concentrations with nephrotoxicity. Four rats from each group were sacrificed daily and renal parenchymal tissue concentrations were determined microbiologically. Nephrotoxicity was assessed by changes in creatinine values in serum, renal creatinine clearances, and pathological scores. There was no indication of aminoglycoside-induced nephrotoxicity in any tests performed. The following steady-state levels resulted: 36, 148, and 176 micrograms/g after 5 mg/kg per day and 148, 260, and 510 micrograms/g after 20 mg/kg per day for tobramycin, gentamicin, and netilmicin, respectively. We conclude that aminoglycoside parenchymal accumulation in rats follows this order: tobramycin less than gentamicin less than netilmicin. Therefore, differences in the relative toxicities of gentamicin, tobramycin, and netilmicin do not correlate with the renal parenchymal accumulation of these agents and may be more dependent on intrinsic toxicity to the renal proximal tubule than to the concentration of the aminoglycoside in the kidney.
将庆大霉素、妥布霉素和奈替米星以每日5或20毫克/千克的剂量给予大鼠,持续30天,以确定这些化合物的肾脏蓄积动力学,并将稳态肾实质浓度与肾毒性相关联。每组每天处死4只大鼠,并通过微生物学方法测定肾实质组织浓度。通过血清肌酐值、肾脏肌酐清除率和病理评分的变化评估肾毒性。在进行的任何测试中均未显示氨基糖苷类药物诱导的肾毒性迹象。以下是稳态水平结果:妥布霉素、庆大霉素和奈替米星每日5毫克/千克给药后分别为36、148和176微克/克,每日20毫克/千克给药后分别为148、260和510微克/克。我们得出结论,大鼠体内氨基糖苷类药物在肾实质中的蓄积顺序为:妥布霉素<庆大霉素<奈替米星。因此,庆大霉素、妥布霉素和奈替米星相对毒性的差异与这些药物在肾实质中的蓄积无关,可能更多地取决于对肾近端小管的内在毒性,而非肾脏中氨基糖苷类药物的浓度。